NM_000489.6:c.4377_4379dupGGA
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_000489.6(ATRX):c.4377_4379dupGGA(p.Glu1460dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000083 in 1,204,434 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000489.6 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATRX | NM_000489.6 | c.4377_4379dupGGA | p.Glu1460dup | disruptive_inframe_insertion | Exon 15 of 35 | ENST00000373344.11 | NP_000480.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000182 AC: 2AN: 110026Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 32396
GnomAD3 exomes AF: 0.0000223 AC: 4AN: 178979Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 65011
GnomAD4 exome AF: 0.00000731 AC: 8AN: 1094408Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 360524
GnomAD4 genome AF: 0.0000182 AC: 2AN: 110026Hom.: 0 Cov.: 21 AF XY: 0.00 AC XY: 0AN XY: 32396
ClinVar
Submissions by phenotype
not provided Uncertain:1Other:1
In-frame duplication of one amino acid in a repetitive region with no known function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 24728327) -
Variant classified as Uncertain significance and reported on 11-23-2022 by GeneDx. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. -
Alpha thalassemia-X-linked intellectual disability syndrome Uncertain:1
This variant, c.4377_4379dup, results in the insertion of 1 amino acid(s) to the ATRX protein (p.Glu1464dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals affected with ATRX-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at